Company intelligence / Profile preview

SonoVascular

Chapel Hill, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

Initial First-in-Human results in deep vein thrombosis showed successful mechanical clot removal utilizing microbubble-mediated cavitation with low-dose tPA, no blood loss, and rapid patient recovery. Eight cases have been completed and initial results are positive with effective thrombus removal and no device-related complications.

Therapeutic areas: Cardiovascular
Modalities: DeviceMicrobubble-mediated cavitationUltrasound-based therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on SonoVascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SonoVascular.

Explore the full profile